XML 50 R81.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments Narrative (Detail) (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Jun. 28, 2009
Jun. 03, 2009
Wyeth [Member]
Mar. 24, 2009
Wyeth [Member]
Dec. 31, 2011
Unused Lines of Credit [Member]
Dec. 31, 2011
Unused Lines of Credit [Member]
Expire in 2016 [Member]
Dec. 31, 2011
Commercial Paper [Member]
Dec. 31, 2010
Commercial Paper [Member]
Dec. 31, 2011
Foreign Exchange Contract [Member]
Dec. 31, 2011
Foreign Exchange Contract [Member]
United Kingdom [Member]
Maturing in 2038 [Member]
Dec. 31, 2011
Interest Rate Contract [Member]
Dec. 31, 2011
Credit Risk Contract [Member]
Dec. 31, 2011
Derivative Instruments Issued By Counterparties [Member]
Short - Term Borrowings:                            
Weighted-average effective interest rate on short-term borrowings outstanding 0.20% 2.80%                        
Commercial paper outstanding               $ 2,700,000,000 $ 1,200,000,000          
Line of credit, maximum borrowing capacity 9,400,000,000                          
Line of credit, current borrowing capacity before expiration 2,300,000,000                          
Line of credit, remaining borrowing capacity           8,600,000,000                
Line of credit, remaining borrowing capacity, amount lenders have committed to loan us           7,500,000,000                
Line of credit, current borrowing capacity able to support commercial paper borrowings before expiration             7,000,000,000              
Derivative Financial Instruments and Hedging Activities                            
Aggregate notional amount of foreign exchange derivative financial instruments                   48,100,000,000        
Notional amount of foreign exchange derivative financial instruments                     2,300,000,000      
Aggregate notional amount of interest rate derivative financial instruments                       10,600,000,000    
Credit Risk Derivatives                            
Aggregate fair value of net derivative liabilities                         502,000,000  
Posted collateral                         555,000,000  
Additional collateral                         46,000,000  
Concentration risk maximum exposure                           2,800,000,000
Securities received as collateral                           491,000,000
Senior unsecured notes     $ 24,000,000,000 $ 10,500,000,000 $ 13,500,000,000